Jonathan Cebon

45.5k citations
277 papers · 13.6k · 6 hit papers · h-index 62

Impact in

  • Immunology top 0.1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune Response and Inflammation
  • Oncology top 0.2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immunotherapy and Immune Responses 104
    • Immune Cell Function and Interaction 32
    • T-cell and B-cell Immunology 31
    • CAR-T cell therapy research 44
    • Cancer Immunotherapy and Biomarkers 37
    • Neutropenia and Cancer Infections 22

Jonathan Cebon

274 papers receiving 13.4k citations

Jonathan Cebon's Hit Papers

A gut microbial signature for combination immune checkpoint blockade across cancer types 2024 · 79 citations
790+10+21Years since publication2505007501000

Peers

Jonathan Cebon
Comparison fields: 5 of 144
  • Immunology 6.1k
  • Oncology 5.4k
  • Hematology 1.0k
  • Molecular Biology 4.2k
  • Physiology 268
Replace Madeleine Duvic with:
Madeleine Duvic United States
Vassiliki A. Boussiotis United States
Ivan D. Horak United States
James L. Riley United States
Giorgio Cattoretti Italy
Salem Chouaı̈b France
Daniel Olive France
Peter Brossart Germany
Claudio Tripodo Italy
Andréas Mackensen Germany
Jonathan Cebon relative to Madeleine Duvic United States Madeleine Duvic's profile →
Citations per field
00.5×3.6×
Madeleine Duvic · 1×
Citations per year

Countries citing papers authored by Jonathan Cebon

Since Specialization
Citations

This map shows the geographic impact of Jonathan Cebon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Cebon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Cebon more than expected).

Fields of papers citing papers by Jonathan Cebon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Cebon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Cebon. The network helps show where Jonathan Cebon may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Cebon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Cebon Line = papers co-authored together Jonathan Cebon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 277 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Hit paper breakdown →
20171165
2
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
Hit paper breakdown →
2000938
3
Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.
Hit paper breakdown →
1994685
4
Type I IFNs Enhance the Terminal Differentiation of Dendritic Cells
Hit paper breakdown →
1998500
5 2002309
6 2006187
7 2004175
8 2017172
9 1996163
10 2004163
11
Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers
Hit paper breakdown →
2020159
12 2002155
13 2008152
14 2003150
15 1997149
16 2019145
17 2015144
18 2020138
19 2007134
20 1994130

About Jonathan Cebon

Jonathan Cebon is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 277 papers that have together received 13.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (104 papers), CAR-T cell therapy research (44 papers), Cancer Immunotherapy and Biomarkers (37 papers), vaccines and immunoinformatics approaches (32 papers), Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (31 papers), Melanoma and MAPK Pathways (27 papers) and Neutropenia and Cancer Infections (22 papers). The work is most often cited by research in Immunology (6.1k citations), Oncology (5.4k citations), Hematology (1.0k citations), Molecular Biology (4.2k citations) and Physiology (268 citations). Jonathan Cebon has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Ian D. Davis, Eugene Maraskovsky, Andreas Behren, Weisan Chen, Graham J. Lieschke, Thomas Luft, George Morstyn, Tracey Toy, Darryl Maher and Georgina V. Long. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, The Journal of Immunology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact